Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Modeling Study in Hospitalized Patients With COVID-19 in the United States
Robert L. Ohsfeldt, Kari Kelton, Tim Klein, Mark Belger, Patrick L. Mc Collam, Theodore E. Spiro, Russel Burge, Neera Ahuja
Topics & Concepts
MedicineQuality-adjusted life yearClinical trialCoronavirus disease 2019 (COVID-19)Quality of life (healthcare)Emergency medicineCost effectivenessDiseaseInternal medicineRisk analysis (engineering)NursingInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19